Used in pharmaceutical research as a key intermediate in the synthesis of selective dopamine reuptake inhibitors. Shows potential in the development of treatments for neurological disorders such as Parkinson’s disease and depression due to its ability to modulate dopaminergic activity. Its structural configuration enhances blood-brain barrier penetration, making it valuable in central nervous system drug design. Also employed in structure-activity relationship (SAR) studies to optimize potency and selectivity in novel psychoactive therapeutics.